AF
Ameriprise Financial Inc disclosed a 8.6% stake in YARW
Ameriprise Financial Inc reported owning 8.6% of Yarrow Bioscience, Inc. (YARW) (739,538 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G